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We note the omission described by Dr. Tsochatzis and colleagues.
We fully agree that the collagen proportionate area (CPA) method
is a valuable tool for quantiﬁcation of ﬁbrotic collagen in diseased
liver and that its correlation with HVPG is an important observa-
tion. However, to our knowledge, CPA has not yet been validated
as a methodology for the assessment of regression of human liver
ﬁbrosis. Critically, the focus of our review was to survey the cur-
rently available data in the published literature that provides evi-
dence for regression of ﬁbrosis across the distinct liver disease
etiologies. Due to this focus and space limitations, we were
unable to undertake a detailed consideration of emerging tech-
nologies that might be applied for detailed analysis of ﬁbrosis
regression, including CPA. We are pleased that Dr. Tsochatzis
has highlighted the likely utility of CPA and look forward to
future work that examines its application in studies of ﬁbrosisModest alcohol consumption and non-alcoholic steatohepatitisRen-Nan Feng
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Guo-Qiang Li
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We read with great interest the article by Dunn et al., published in
March 2012 [1]. This cross-sectional study reported some inter-
esting observations on the relationship between modest alcohol
consumption and non-alcoholic steatohepatitis (NASH). However,
the study has some limitations.
Dunn et al., clearly demonstrated that modest alcohol con-
sumption was signiﬁcantly inversely associated with NASH,
which was consistent with other recent studies [2,3]. However,
some important confounding factors were not considered or dis-
cussed. First, the rate of diabetes in the lifetime non-drinkers
was signiﬁcantly higher than that of modest drinkers (37.5% vs.
22.1%), but this was not included as a covariant in the multiple
logistic regression analysis. As subjects with diabetes are more
prone to have fatty liver disease, this difference should be consid-
ered in the analysis. Second, soft drinks consumption might also
be an important factor. Early studies have reported that soft
drinks, especially fructose, contribute to the development of dia-
betes and non-alcoholic fatty liver disease (NAFLD) [4]. In addi-
tion, lifetime non-drinkers may drink more soft drinks than
modest drinkers do, which may also affect the result. However,
this confounding factor was not mentioned or discussed in the
article either. Third, as the mechanisms of the inverse association
between alcohol consumption and NAFLD or NASH are still
unclear, genetic factors might be the answer to this question.
Alcohol consumption might interact with some genetic factors
and lead to NAFLD or NASH. We believe the authors have consid-
ered this and investigated several SNPs, ﬁnding that PNPLA3 geno-
type was signiﬁcantly different between the two groups. Again,
this polymorphism was not included in the multiple logistic
regression analysis. Thus, in our opinion, future studies should
consider all the above mentioned factors, which would help inter-
pret their important ﬁndings.Journal of Hepatology 20
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To the Editor:
We studied the association of modest alcohol consumption and
steatohepatitis in a large sample of well-characterized study par-
ticipants with biopsy-proven non-alcoholic fatty liver disease
(NAFLD) from referral centers across the United States. Modest
alcohol consumption was associated with signiﬁcantly lower
odds of non-alcoholic steatohepatitis (NASH). Feng et al. raise
questions about diabetes and soft drink consumption as potential
confounders.
The ﬁrst question about diabetes speaks to one possible mech-
anism by which alcohol could lower the odds for NASH. Diabetes
has consistently been shown to be a major risk factor for steato-
hepatitis. In order to be considered a confounder, a factor must be
associated with both the exposure and outcome, but cannot be in
the causal pathway. Therefore, our main analysis did not include
the diagnosis of diabetes as a confounder because diabetes is
thought to be in the causal pathway. We did, however, perform
a series of sensitivity analyses to address such issues. Sensitivity
analysis #4 adjusted for the diagnosis of diabetes and showed
that the odds ratio between modest alcohol and NASH was atten-
uated from 0.52 (95% CI 0.36–0.76) to 0.58 (95% CI 0.41–0.84).
Thus as evidenced by this small attenuation, the effect of modest
alcohol on steatohepatitis may in part be manifested through
reduced prevalence of diabetes, but this is not likely to be the
major explanation for the lower odds of steatohepatitis.
While we adjusted for an extensive list of social, demographic
and lifestyle covariates, the possibility remains for any epidemi-
ology study that the exposure of interest is a surrogate marker of
other unmeasured factors. The second question posed by Feng
et al. was whether non-drinkers may consume greater amounts
of soft drinks, especially those containing fructose. Thus, soft
drink consumption could be one of the unmeasured factors,
because previous data has suggested an association between
fructose consumption and an increased risk for NAFLD [1,2] and
NASH. We performed a literature search, but were unable to ﬁnd
published studies comparing soft drink consumption between
non-drinkers and modest drinkers. Thus it is unclear whether
the amount of soft drink consumption was different between
our two groups. However, in our main analysis we did adjust
for total calories per day and percent calories from carbohydrates.
Neither of these adjustments attenuated the association between
modest alcohol and lower odds of having NASH.
Beyond issues of mechanism and statistical analyses, the
question of whether or not to permit adult patients with NAFLDJournal of Hepatology 201
ess under CC BY-NC-ND license.to drink alcohol in modest amounts remains controversial. As
opposed to being harmful, many studies now support the belief
that modest alcohol consumption in adults with NAFLD could
be beneﬁcial. However, to date no studies can deﬁnitively
support nor refute this contention. Therefore, hepatologists are
not uniﬁed on this issue and thus fall into one of three camps:
(1) those that continue to recommend strict avoidance; (2) those
that counsel their patients that heavy drinking is bad, but that
there is not enough evidence to know whether modest alcohol
is good or bad, and (3) those that have taken to proactively
recommending one alcoholic beverage a few times per week. In
order to move past the controversy and know how to best coun-
sel our patients will require collaborations to further build the
evidence than can support a clinical consensus.
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